|
|
You have requested access to the following
article:
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
.
The Lancet
, Volume
370
, Issue
9581
, Pages
29
-
38
J
.
Madruga
,
P
.
Cahn
,
B
.
Grinsztejn
,
R
.
Haubrich
,
J
.
Lalezari
,
A
.
Mills
,
G
.
Pialoux
,
T
.
Wilkin
,
M
.
Peeters
,
J
.
Vingerhoets
|